SPARC announces Phase 3 trial results of SDN-037 to treat inflammation and pain of ocular surgery EP News Bureau Oct 14, 2020 The primary efficacy measure was the proportion of subjects with an anterior chamber cell (ACC) grade of zero (0) on Day 15 (zero…
